PM1 prepares to establish JORC compliant Resource at Battery Hub

Published 28-SEP-2017 12:30 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Just a fortnight after announcing that a license had been granted for the company’s Battery Hub tenement located in Western Australia, Pure Minerals (ASX: PM1) has delivered a double dose of good news, firstly announcing that a drilling program had been submitted in relation to the project which should provide a maiden JORC 2012 compliant resource.

Management also advised that initial rock chip assays from the Pools prospect included a high-grade result of 47% manganese, indicating that the company has identified a new drilling target.

Note that it is an early stage of this company’s development and if considering this stock for your portfolio you should take all public information into account and seek professional financial advice.

The initial focus of the Battery Hub drilling campaign will be on zones of high-grade and thick manganese mineralisation identified in a detailed review of historic drilling completed by the company and the recent rock chip sampling. These zones are expected to yield the best results in terms of delivering a JORC 2012 compliant Resource.

The planned drilling program is extensive, comprising more than 50 reverse circulation (RC) drill holes over a distance of more than 2000 metres. As indicated below, the initial drill targets are expected to be the Isle and Julia prospects.

Dooley prospect pure minerals

High-grade surface mineralisation above direct shipping threshold

While numerous manganese prospects are known to occur along the entire strike length of the Battery Hub host formation, PM1 is focusing on areas that have received minimal attention in the past. One such area is the Pools prospect, indicating the importance of the recent high-grade assays that have been delineated.

The Pools prospect occurs more than five kilometres along strike to the west of the Julia prospect which has been the focus of historic drilling activities. The outcrop represents a gently dipping zone of mineralisation of more than nine metres in width at surface, with a strike length of approximately 100 metres.

Commenting on these latest developments and highlighting their significance in terms of future exploration, PM1’s Executive Director and Chief Executive Sean Keenan said, “Pure Minerals is in the fortunate position of being able to utilise a historic database of more than 500 drill holes to assist in the planning of drilling and resource definition”.

Keenan noted that the surface results have identified extensive zones of manganese mineralisation with enriched grades that are above the thresholds for direct shipping, as well as new high priority targets for follow-up drilling.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free